JLE

European Journal of Dermatology

MENU

The potential role of serum polyclonal free light chains as markers of immune activation in psoriatic patients Volume 33, issue 1, January-February 2023

Figure 1

A) Free light chains (FLCs) in psoriatic (Pso) and healthy control subjects (Ctrl). B) FLCs in Pso subjects with ongoing (Tx) and without any treatment (No Tx). C) FLCs in responder (R) and non-responder (NR) Pso subjects. Data are presented as mean±SD. Statistical analysis was performed using the Mann-Whitney test with respect to Ctrl. *p<0.05; **p<0.01.

Figure 2

Correlation of k FLCs (A) or λ FLCs (B) with treatment duration. Statistical analysis was performed using the non-parametric Spearman’s rho test.

Figure 3

Free light chains (FLCs) in psoriatic patients at baseline (W0) and after 16 weeks (W16) of ADA therapy. Data are presented as mean±SD. Statistical analysis was performed using the Mann-Whitney test with respect to Ctrl. *p<0.05.